Journal of Neurology

, Volume 254, Supplement 2, pp II73–II76 | Cite as

Neuropsychiatric syndromes associated with multiple sclerosis

  • Anthony Feinstein


Multiple sclerosis is associated with diverse behavioral changes. Rates of major depression approach 50% over the course of patients' lives, rates of bipolar disorder and psychosis are twice as common when compared to rates in the general population and pseudobulbar affect will afflict one in ten patients. However, these disorders often respond well to pharmacologic treatment and in the case of major depression, some forms of psychotherapy too. This article summarizes these mental state changes, their pathogenesis and treatment. Correct diagnosis and treatment can substantially improve the quality of life for MS patients.

Key words

depression mania psychosis personality multiple sclerosis treatment 


  1. 1.
    Asghar A, Taber KH, Hurley RA, Hayman LA (2004) Pure neuropsychiatric presentation of multiple sclerosis. Am J Psychiatry 161:226–231CrossRefGoogle Scholar
  2. 2.
    Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V et al. (2000) Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport 11:1153–1158PubMedCrossRefGoogle Scholar
  3. 3.
    Beck AT, Steer RA, Brown GK (2000) BDI-Fast Screen for Medical Patients Manual. The Psychological Corporation, San Antonio, TxGoogle Scholar
  4. 4.
    Benedict RH, Fishman I, McClellan MM, Bakshi R,Weinstock-Guttman B (2003) Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Multi Scler 9:393–396CrossRefGoogle Scholar
  5. 5.
    Davison K, Bagley CR (1969) Schizophrenia- like psychoses associated with organic disorders off the central nervous system. A review of the literature. In: Herrington RN (ed) Current problems in neuropsychiatry. Hedley, Ashford, Kent, pp 113–184Google Scholar
  6. 6.
    Feinstein A (2000) Multiple sclerosis, depression and disease modifying drugs. Mult Scler 6:343–348PubMedGoogle Scholar
  7. 7.
    Feinstein A (2002) An examination of suicidal intent in patients with multiple sclerosis. Neurology 59:674–678PubMedGoogle Scholar
  8. 8.
    Feinstein A, du Boulay G, Ron MA (1992) Psychotic illness in multiple sclerosis.A clinical and magnetic resonance imaging study. Br J Psychiatry 161:680–685PubMedCrossRefGoogle Scholar
  9. 9.
    Feinstein A, Feinstein KJ, Gray T, O'Connor P (1997) The prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol 54:1116–1121PubMedGoogle Scholar
  10. 10.
    Feinstein A, O'Connor P, Gray T, Feinstein KJ (1999) The pathogenesis of pathological laughing and crying in multiple sclerosis: a role for the prefrontal cortex? Mult Scler 5:69–73PubMedGoogle Scholar
  11. 11.
    Feinstein A, Roy P, Lobaugh N, Feinstein KJ, O'Connor P (2004) Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 62:586–590PubMedGoogle Scholar
  12. 12.
    Flax JW, Gray J, Herbert J (1991) Effects of fluoxetine on patients with multiple sclerosis. Am J Psychiatry 148:1603PubMedGoogle Scholar
  13. 13.
    Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Personal and family history of affective disorder. J Affect Disord 12:63–65PubMedCrossRefGoogle Scholar
  14. 14.
    Lynch SG. Kroencke DC, Denney DR (2001) The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping and hope. Mult Scler 7:411–416PubMedGoogle Scholar
  15. 15.
    Minden SL, Schiffer RB (1990) Affective disorders in multiple sclerosis: Review and recommendations for clinical research. Arch Neurol 47:98–104PubMedGoogle Scholar
  16. 16.
    Mohr DC, Boudewyn AC, Goodkin D, Bostrom A, Epstein L (2001) Comparative outcomes for individual cognitivebehavior therapy, supportive-expressive group therapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 69:942–949PubMedCrossRefGoogle Scholar
  17. 17.
    Panitch HS, Thisted RA, Smith RA, Wynn DR,Wymer JP et al. (2006) Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 59:780–787PubMedCrossRefGoogle Scholar
  18. 18.
    Patten SB, Beck CA, Williams JVA, Barbui C, Metz LM (2003) Major depression in multiple sclerosis. A population-based perspective. Neurology 61:1524–1527PubMedGoogle Scholar
  19. 19.
    Patten SB, Svenson LW, Metz LM (2005) Psychotic disorders in MS: Population-based evidence of an association. Neurology 65:1123–1125PubMedCrossRefGoogle Scholar
  20. 20.
    Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A (1997) Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 49:1105–1110PubMedGoogle Scholar
  21. 21.
    Rabins PV (1990) Euphoria in multiple sclerosis. In: Rao SM (ed) Neurobehavioral aspects of multiple sclerosis. Oxford University Press, New York, pp 180–185Google Scholar
  22. 22.
    Sadovnik AD, Eisen RN, Ebers GC, Paty DW (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology 41:1193–1196Google Scholar
  23. 23.
    Schiffer RB, Herndon RM, Rudick RA (1983) Treatment of pathologic laughter and weeping with amitriptyline. NEJM 312:1480–1482Google Scholar
  24. 24.
    Schiffer RB, Wineman NM (1990) Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147:1493–1497PubMedGoogle Scholar
  25. 25.
    Schubert RSB, Foliart RH (1993) Increased depression in multiple sclerosis: A meta-analysis. Psychosomatics 34:124–130PubMedGoogle Scholar
  26. 26.
    Seliger GM, Hornstein A, Flax J, Herbert J, Schroder K (1992) Fluoxetine improves emotional incontinence. Brain Inj 6:267–270PubMedGoogle Scholar
  27. 27.
    Stenager EN, Stenager E (1992) Suicide and patients with neurologic diseases. Methodologic problems. Arch Neurol 49:1296–1303PubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2007

Authors and Affiliations

  1. 1.Dept. of PsychiatryUniversity of Toronto, Sunnybrook Health Sciences CentreTorontoCanada M4N 3M5

Personalised recommendations